Periodic Reporting for period 1 - MELASTOP (Discovery of mevalonate and UBIAD1 inhibitors as novel drugs targeting melanoma skin cancer)

Since melanoma is the most aggressive skin tumor, there is an urgent need for development of novel drugs that can cure and prolong the survival of melanoma patients. In this ERC-PoC grant named MELASTOP we have investigatesd the mevalonate metabolic pathway as a new target to...